![Andy Bass](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andy Bass
No más puestos en curso
Perfil
Andy Bass is the founder of Biological & Popular Culture, Inc. Prior to founding the company, he worked as the Director of Business Development at Cellectis, Inc. and as the Senior Vice President of the Consumer Sector at Precigen, Inc. He received his undergraduate degree from The University of Alabama at Birmingham.
Antiguos cargos conocidos de Andy Bass.
Empresas | Cargo | Fin |
---|---|---|
Biological & Popular Culture, Inc.
![]() Biological & Popular Culture, Inc. Home FurnishingsConsumer Durables Biological & Popular Culture, Inc. manufactures fine and decorative artworks, accessories and toys. The company was founded by Dean Sauer and Andy Bass and is headquartered in Carlsbad, CA. | Director Ejecutivo | - |
Cellectis, Inc.
![]() Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Corporate Officer/Principal | - |
PRECIGEN, INC. | Corporate Officer/Principal | - |
Formación de Andy Bass.
The University of Alabama at Birmingham | Undergraduate Degree |
Experiencias
Funciones ocupadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PRECIGEN, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Biological & Popular Culture, Inc.
![]() Biological & Popular Culture, Inc. Home FurnishingsConsumer Durables Biological & Popular Culture, Inc. manufactures fine and decorative artworks, accessories and toys. The company was founded by Dean Sauer and Andy Bass and is headquartered in Carlsbad, CA. | Consumer Durables |
Cellectis, Inc.
![]() Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Health Technology |
- Bolsa de valores
- Insiders
- Andy Bass